125 related articles for article (PubMed ID: 11834244)
21. Neuropeptide Y-mediated enhancement of NMDA-stimulated [3H]dopamine release from rat prefrontal cortex is reversed by sigma1 receptor antagonists.
Ault DT; Werling LL
Schizophr Res; 1998 May; 31(1):27-36. PubMed ID: 9633834
[TBL] [Abstract][Full Text] [Related]
22. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
23. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
Bergeron R; Debonnel G
Psychopharmacology (Berl); 1997 Feb; 129(3):215-24. PubMed ID: 9084059
[TBL] [Abstract][Full Text] [Related]
24. Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
Hong W; Werling L
Brain Res; 2001 May; 901(1-2):208-18. PubMed ID: 11368969
[TBL] [Abstract][Full Text] [Related]
25. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
[TBL] [Abstract][Full Text] [Related]
26. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain.
Chaki S; Okuyama S; Ogawa S; Tanaka M; Muramatsu M; Nakazato A; Tomisawa K
Life Sci; 1996; 59(16):1331-40. PubMed ID: 8876662
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classes.
de Costa BR; Dominguez C; He XS; Williams W; Radesca L; Bowen W
J Med Chem; 1992 Nov; 35(23):4334-43. PubMed ID: 1447735
[TBL] [Abstract][Full Text] [Related]
28. Functional and binding properties of sigma receptors in rat cerebellum.
Gonzalez-Alvear GM; Thompson-Montgomery D; Deben SE; Werling LL
J Neurochem; 1995 Dec; 65(6):2509-16. PubMed ID: 7595545
[TBL] [Abstract][Full Text] [Related]
29. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.
Vilner BJ; Bowen WD
J Pharmacol Exp Ther; 2000 Mar; 292(3):900-11. PubMed ID: 10688603
[TBL] [Abstract][Full Text] [Related]
30. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
31. Regulation of [3H]norepinephrine release from guinea pig hippocampus by sigma2 receptors.
Weatherspoon JK; Gonzalez-Alvear GM; Werling LL
Eur J Pharmacol; 1997 May; 326(2-3):133-8. PubMed ID: 9196265
[TBL] [Abstract][Full Text] [Related]
32. Stereoselective inhibition of natural killer activity by the sigma ligand (+)-pentazocine.
Maity R; Mukherjee R; Skolnick P
J Neuroimmunol; 1996 Oct; 70(1):7-13. PubMed ID: 8862129
[TBL] [Abstract][Full Text] [Related]
33. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture.
Brent PJ; Pang GT
Eur J Pharmacol; 1995 May; 278(2):151-60. PubMed ID: 7671999
[TBL] [Abstract][Full Text] [Related]
34. Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors.
Entrena JM; Cobos EJ; Nieto FR; Cendán CM; Baeyens JM; Del Pozo E
Psychopharmacology (Berl); 2009 Jul; 205(1):21-33. PubMed ID: 19326101
[TBL] [Abstract][Full Text] [Related]
35. Multiple [3H]-nemonapride binding sites in calf brain.
Helmeste DM; Tang SW; Li M; Fang H
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):17-21. PubMed ID: 9228185
[TBL] [Abstract][Full Text] [Related]
36. Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system.
Carr DJ; De Costa BR; Radesca L; Blalock JE
J Neuroimmunol; 1991 Dec; 35(1-3):153-66. PubMed ID: 1955564
[TBL] [Abstract][Full Text] [Related]
37. Sigma receptor activation does not mediate fentanyl-induced attenuation of muscarinic coronary contraction.
Tsuchida H; Schubert A; Estafanous FG; Brum JM; Murray PA
Anesth Analg; 1996 May; 82(5):982-7. PubMed ID: 8610910
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
39. Intrasynaptosomal free calcium levels in rat forebrain synaptosomes: modulation by sigma (sigma) receptor ligands.
Brent PJ; Saunders H; Dunkley PR
Neurosci Lett; 1996 Jun; 211(2):138-42. PubMed ID: 8830864
[TBL] [Abstract][Full Text] [Related]
40. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin.
DeHaven-Hudkins DL; Ford-Rice FY; Allen JT; Hudkins RL
Life Sci; 1993; 53(1):41-8. PubMed ID: 8515681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
